REVACTIEF
ActiveSummary
REVACTIEF has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €210,805 and a net result of €86,256. Equity is growing by ~43.8% per year across the filed fiscal years. Its solvency ranks better than 34% of 2356 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability89▼-2
Solvency65▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16,000 at 30 days acceptable
Liquidity tight (current ratio 1.34 against 1.48 in 2024; short-term debt: 35.1% and cash: 9.5% of total assets), and 59.8% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
40.2%
Return on assets
16.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
25 d early
2024
66 d early
2023
27 d late
2022
31 d early
2021
30 d late
2020
31 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 6 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€210,805▲ 5.6%
2024 · €199,672
Total assets
€524,309▲ 3.1%
2024 · €508,406
Net result
€86,256▼ 3.6%
2024 · €89,513
Working capital
€62,610▼ 2.5%
2024 · €64,215
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€30,330▼ 35.9%€53,925▲ 77.8%€51,142▼ 5.2%€131,109▲ 156%€119,968▼ 8.5%
Net result€14,803below the sector's middle half▼ 53.8%€28,248within the sector's middle half▲ 90.8%€30,036below the sector's middle half▲ 6.3%€89,513within the sector's middle half▲ 198%€86,256within the sector's middle half▼ 3.6%
Equity€51,875below the sector's middle half▲ 39.9%€80,123within the sector's middle half▲ 54.5%€110,159below the sector's middle half▲ 37.5%€199,672within the sector's middle half▲ 81.3%€210,805within the sector's middle half▲ 5.6%
Total assets€520,410within the sector's middle half▲ 19.0%€527,604within the sector's middle half▲ 1.4%€488,159within the sector's middle half▼ 7.5%€508,406within the sector's middle half▲ 4.1%€524,309within the sector's middle half▲ 3.1%
Debt€468,534▲ 17.0%€447,481▼ 4.5%€378,000▼ 15.5%€308,733▼ 18.3%€313,504▲ 1.5%
Working capital-€52,643▲ 60.7%-€43,392▲ 17.6%-€33,500▲ 22.8%€64,215€62,610▼ 2.5%
Solvency10.0%below the sector's middle half▲ 1.5pp15.2%below the sector's middle half▲ 5.2pp22.6%below the sector's middle half▲ 7.4pp39.3%within the sector's middle half▲ 16.7pp40.2%within the sector's middle half▲ 0.9pp
Staff (FTE)0below the sector's middle half0below the sector's middle half0below the sector's middle half
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €524,309
Fixed assets
€277,546 ▼ 11.0%
Current assets
€246,764 ▲ 25.5%
Equity and liabilities €524,309
Equity
€210,805 ▲ 5.6%
Debt
€313,504 ▲ 1.5%
Debt's share of the balance-sheet total falls from 60.7% to 59.8%. Equity and debt are higher.
Key figures and ratios
EBITDA
€179,265▼
2024 · €201,208
Cash flow
€145,553▼
2024 · €159,613
Current ratio
1.34▼
2024 · 1.48
Debt to equity
1.49▼
2024 · 1.55
ROE
40.9%▼
2024 · 44.8%
ROA
16.5%▼
2024 · 17.6%
Interest coverage
22.70▲
2024 · 22.36
Debt ≤ 1 year
€184,154▲
2024 · €132,439
Debt > 1 year
€129,039▼
2024 · €175,916
Income taxes
€34,360▼
2024 · €39,222
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,776 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.5%
went bankrupt
2.6%
stopped otherwise
97%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,776 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €5,750 | €826 | €7,175 | ▲ 768% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €46,643 | €36,402 | €37,865 | €70,100 | €59,297 | ▼ 15.4% |
| Other operating charges640/8 | €3,308 | €3,093 | €3,594 | €2,623 | €2,525 | ▼ 3.8% |
| Gross operating margin9900 | €80,281 | €93,420 | €92,602 | €203,832 | €181,790 | ▼ 10.8% |
| Operating profit (loss)9901 | €30,330 | €53,925 | €51,142 | €131,109 | €119,968 | ▼ 8.5% |
| Financial income75/76B | €990 | €2,125 | €3,296 | €6,625 | €8,543 | ▲ 28.9% |
| Recurring financial income75 | €990 | €2,125 | €3,296 | €6,625 | €8,543 | ▲ 28.9% |
| Financial charges65/66B | €14,160 | €13,333 | €11,232 | €8,998 | €7,896 | ▼ 12.3% |
| Recurring financial charges65 | €14,160 | €13,333 | €11,232 | €8,998 | €7,896 | ▼ 12.3% |
| Profit (loss) for the period before taxes9903 | €17,159 | €42,717 | €43,206 | €128,736 | €120,615 | ▼ 6.3% |
| Income taxes67/77 | €2,356 | €14,469 | €13,170 | €39,222 | €34,360 | ▼ 12.4% |
| Profit (loss) for the period9904 | €14,803 | €28,248 | €30,036 | €89,513 | €86,256 | ▼ 3.6% |
| Profit (loss) for the period to be appropriated9905 | €14,803 | €28,248 | €30,036 | €89,513 | €86,256 | ▼ 3.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €520,410 | €527,604 | €488,159 | €508,406 | €524,309 | ▲ 3.1% |
| Fixed assets21/28 | €432,529 | €402,468 | €372,335 | €311,751 | €277,546 | ▼ 11.0% |
| Intangible fixed assets21 | €237,825 | €225,256 | €212,687 | €185,118 | €165,089 | ▼ 10.8% |
| Tangible fixed assets22/27 | €194,705 | €177,212 | €159,648 | €126,633 | €112,457 | ▼ 11.2% |
| Plant, machinery and equipment23 | €72,364 | €64,017 | €54,945 | €36,134 | €27,687 | ▼ 23.4% |
| Furniture and vehicles24 | €14,685 | €13,506 | €11,139 | €9,269 | €13,952 | ▲ 50.5% |
| Leasing and similar rights25 | €36,709 | €33,816 | €31,922 | €24,029 | €16,135 | ▼ 32.9% |
| Other tangible fixed assets26 | €70,947 | €65,874 | €61,641 | €57,201 | €54,682 | ▼ 4.4% |
| Current assets29/58 | €87,880 | €125,136 | €115,824 | €196,654 | €246,764 | ▲ 25.5% |
| Amounts receivable after more than one year29 | - | - | €22,000 | €27,500 | €27,500 | = |
| Other amounts receivable291 | - | - | €22,000 | €27,500 | €27,500 | = |
| Amounts receivable within one year40/41 | €52,543 | €65,078 | €73,612 | €121,002 | €156,476 | ▲ 29.3% |
| Trade receivables40 | €1,700 | €10,495 | €13,860 | €7,918 | €1,422 | ▼ 82.0% |
| Other amounts receivable41 | €50,843 | €54,583 | €59,752 | €113,084 | €155,054 | ▲ 37.1% |
| Cash at bank and in hand54/58 | €33,886 | €53,870 | €11,292 | €34,399 | €49,879 | ▲ 45.0% |
| Deferred charges and accrued income490/1 | €1,451 | €6,188 | €8,920 | €13,753 | €12,908 | ▼ 6.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €520,410 | €527,604 | €488,159 | €508,406 | €524,309 | ▲ 3.1% |
| Equity10/15 | €51,875 | €80,123 | €110,159 | €199,672 | €210,805 | ▲ 5.6% |
| Contributions10/11 | €5,000 | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Reserves13 | €46,875 | €75,123 | €105,159 | €194,672 | €205,805 | ▲ 5.7% |
| Distributable reserves133 | €46,875 | €75,123 | €105,159 | €194,672 | €205,805 | ▲ 5.7% |
| Profit (loss) carried forward14 | - | - | - | - | €0 | - |
| Amounts payable17/49 | €468,534 | €447,481 | €378,000 | €308,733 | €313,504 | ▲ 1.5% |
| Amounts payable after more than one year17 | €327,793 | €278,443 | €227,830 | €175,916 | €129,039 | ▼ 26.6% |
| Financial debts170/4 | €327,793 | €278,443 | €227,830 | €175,916 | €129,039 | ▼ 26.6% |
| Amounts payable within one year42/48 | €140,523 | €168,528 | €149,324 | €132,439 | €184,154 | ▲ 39.0% |
| Current portion of amounts payable after more than one year42 | €51,107 | €54,856 | €53,727 | €55,094 | €50,125 | ▼ 9.0% |
| Trade debts44 | €8,741 | €42,172 | €51,068 | €49,953 | €54,547 | ▲ 9.2% |
| Suppliers440/4 | €8,741 | €42,172 | €51,068 | €49,953 | €54,547 | ▲ 9.2% |
| Taxes, remuneration and social security45 | €18,281 | €26,963 | €18,292 | €27,392 | €4,360 | ▼ 84.1% |
| Taxes450/3 | €15,950 | €23,919 | €3,170 | €27,392 | €4,360 | ▼ 84.1% |
| Remuneration and social security454/9 | €2,331 | €3,044 | €15,123 | €0 | - | - |
| Other amounts payable47/48 | €62,395 | €44,537 | €26,237 | €0 | €75,123 | - |
| Accrued charges and deferred income492/3 | €218 | €510 | €846 | €379 | €311 | ▼ 17.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €14,803 | €28,248 | €30,036 | €89,513 | €86,256 | ▼ 3.6% |
| + Depreciation and write-downs630 | €46,643 | €36,402 | €37,865 | €70,100 | €59,297 | ▼ 15.4% |
| Operating cash flow (approximation) | €61,446 | €64,649 | €67,902 | €159,613 | €145,553 | ▼ 8.8% |
| Investment in fixed assets (approximation) | - | -€6,341 | -€7,732 | -€9,516 | -€25,091 | ▼ 164% |
| Change in cash | - | €19,984 | -€42,578 | €23,107 | €15,480 | ▼ 33.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Equity above €200,000Eq €210,805 ▲5.6%
6 profitable years in a row build equity to €210,805.
26-05
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2020net €89,513 ▲198%
Operating result €131,109, net result €89,513, both a record.
31-12
Financial
Equity above €150,000Eq €199,672 ▲81.3%
5 profitable years in a row build equity to €199,672.
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 27 days late
2023
31-12
Financial
Equity above €100,000Eq €110,159 ▲37.5%
4 profitable years in a row build equity to €110,159.
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
31-12
Financial
Weakest financial yearnet €14,803 ▼53.8%
Net result drops to €14,803, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Niel · 1 establishment unit since 2020
Ground area
538 m²
Building footprint
263 m²
Volume, LiDAR
380 m³
2 parcels, Flanders · tallest building 6.0 m, ±1 floor. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
REVACTIEF
since 20202.298.230.995
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11030A0127/00G004 | Flanders | 357 m² | 1 · 145 m² | 5.6 m |
| 11030A0128/00T004 | Flanders | 181 m² | 1 · 118 m² | 6.0 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2024 · 3 entries · 1,449 EUR awarded · 1,449 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 201 EUR | 201 EUR |
| 2023 | 1 | 1,218 EUR | 1,218 EUR |
| 2022 | 1 | 30 EUR | 30 EUR |
Similar companies · same sector, comparable size
OSTEFIT
BE 0822.325.121
Ath · Eq €210,532
Centre Paramédical Schuman
BE 0544.314.906
Waterloo · Eq €211,098
Kinemotion
BE 0502.965.190
Oud-Turnhout · Eq €211,772
KINE VAN DEN BERGH
BE 0864.142.019
Antwerpen · Eq €209,447
VERPAELE SOPHIE
BE 0472.015.658
Kaprijke · Eq €209,364
Of 12,699 companies in sector 86951 we hold annual accounts for 2,146. 1,597 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded16-01-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
68201Renting and operating of own or leased residential real estate, excluding social housing
E-invoicing
Reachable via Peppol
Peppol ID
0208:0741626663
Also
9925:BE0741626663
Registered
20-12-2024
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.